Health · 10 June 2026

Scientists find why Ozempic fails for some people

Unsplash / Markus Winkler

Researchers have identified genetic variants that appear to make some people far less responsive to GLP-1 drugs such as Ozempic and Mounjaro. Roughly 10% of the population carries these variants, which seem to cause a form of GLP-1 resistance that blunts the medication's effect. The finding could help doctors predict who will benefit from the drugs before prescribing them.

By BriefTea Editorial · 10 June 2026 at 13:01

Reported by ScienceDaily · How we write briefs

Get the app

More briefs

HealthMany NHS Trusts Turn Down Palantir's Patient Data Platform TechnologyRussian Suspect in Deadly London Hospitals Hack Held in Germany HealthGreat Ormond Street's Same-Day Test Finds Hidden Infections in Sick Children HealthImmune cell found to kill small cell lung cancer in lab tests HealthDiabetics sleeping 8+ hours face nearly double kidney disease risk HealthNo perfect age to start HRT, but benefits peak before 60, experts say More health stories → Browse all stories →